Lv1
58 积分 2025-11-26 加入
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment
19天前
已完结
Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022
21天前
已完结
Comprehensive Review of Conventional, Targeted, Immunological and Emerging Therapies in Cancer Treatment
1个月前
已关闭
Molecular tests for prediction of tumor sensitivity to cytotoxic drugs
1个月前
已完结
WHO Classification of Tumours: evolution of a global resource in the molecular era
1个月前
已完结
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
1个月前
已完结
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
1个月前
已完结
Targeting the EGFR signalling pathway in metastatic colorectal cancer
1个月前
已完结
Molecular Pathways: Sensitivity and Resistance to Anti-EGFR Antibodies
1个月前
已完结
Targeted doublet therapy with encorafenib and cetuximab for BRAF V600E-mutant metastatic colorectal cancer: A systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
